Vimarsana
Biggest News Aggregation in the World

Page 11 - Invo Bioscience News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invo Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invo Bioscience Today - Breaking & Trending Today

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022 - Vimarsana News

INVO Bioscience to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Thursday, March 31, 2022

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its...

INVO Bioscience (NASDAQ:INVO) Rating Reiterated by Colliers Securities - Vimarsana News

INVO Bioscience (NASDAQ:INVO) Rating Reiterated by Colliers Securities

INVO Bioscience (NASDAQ:INVO – Get Rating)‘s stock had its “buy” rating reissued by Colliers Securities in a report released on Tuesday, Zacks.com reports. INVO has been the subject of a number of other reports. Maxim Group started coverage on shares of INVO Bioscience in a report on Wednesday, January 19th. They set a “buy” rating […]

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Drops By 44.2% - Vimarsana News

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Drops By 44.2%

INVO Bioscience, Inc. (NASDAQ:INVO – Get Rating) was the target of a large decline in short interest in the month of February. As of February 15th, there was short interest totalling 42,200 shares, a decline of 44.2% from the January 31st total of 75,600 shares. Based on an average trading volume of 43,700 shares, the […]

INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization - Vimarsana News

INVO Bioscience Enters into Agreement with Ovoclinic in Spain to Expand INVOcell Commercialization

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC),...

INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference - Vimarsana News

INVO Bioscience to Participate in the Lytham Partners Winter 2021 Investor Conference

/PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo culture system (IVC),...